抗血小板治疗在缺血性脑血管病预防中的应用

来源 :中国实用内科杂志 | 被引量 : 0次 | 上传用户:silawangyue
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
预防为主是脑血管病防治的关键,发生了致残性脑梗死后再去解决问题,为时已晚。所以,必须从疾病的上游入手,解决源头问题,变被动为主动才是防治缺血性脑血管病(ischemic cerebral vascular disease,ICVD)的根本策略。1ICVD的抗血小板治疗血小板源于骨髓巨核细胞,无核,外观呈盘形 Prevention is the key to prevention and treatment of cerebrovascular disease, the occurrence of disabling cerebral infarction to solve the problem, it is too late. Therefore, we must start from the upper reaches of the disease to solve the source of the problem, change from passive to active is the basic strategy for the prevention and treatment of ischemic cerebral vascular disease (ICVD). 1ICVD anti-platelet therapy Platelet derived from bone marrow megakaryocytes, non-nuclear, the appearance was disc-shaped
其他文献
急性脑梗死是临床的常见病,且发病率、致残率、病死率均较高,给家庭及社会带来沉重的负担,目前除溶栓之外尚无疗效确切的治疗方法。溶栓治疗有严格的治疗时间窗,临床应用受到